The latest offerings in investments, such as funds and structured products, and other notable developments.
Baillie Gifford has launched a UK OEIC Health Innovation Fund, which invests in a new generation of companies tackling the world’s health challenges.
The new OEIC will sit alongside the Dublin-registered UCITS fund which was made available to external investors in April this year, having been launched on 1 October 2018 with an initial investment from Baillie Gifford partners.
Total assets under management for the Baillie Gifford Health Innovation UCITS fund are currently $113 million plus an additional $206 million in segregated mandates.
Both funds are managed by a team of three: Julia Angeles, Rose Nguyen and Marina Record plus an advisory group of five other investment managers. Performance will be measured over five years or more.
The portfolio has around 35 listed mid-size high-growth companies, which are driving transformational changes in the future of healthcare with pioneering therapies, diagnostics and digital technology.